380
29
Pandemics
the utility of a mathematical model: “The essential value of models is that operations
on the models enable conclusions to be drawn about the behaviour of the system
represented”.
In the spirit of drug discovery (Chap. 27), sequence knowledge implying knowl-
edge of the structure of viral gene products (especially when informed by an actual
crystallographic structure determination of at least one variant) can serve to identify
possible vaccine targets, as well as targets for antiviral drugs. Genome analysis should
by no means be restricted to the genome of the virus itself. SARS-CoV-2-infected
respiratory cells not only have altered expression patterns, but genes, isoforms and
transposable elements may also be altered. 4
The rapid worldwide spread of SARS-CoV-2, enormously facilitated by mass
international air travel, has led to rapid evolution of the virus. This has made phylo-
genetic analysis (Sect. 17.7) of especial value. Genomic surveillance can reveal how
transmission occurs between individuals more informatively than the contact tracing
that became de rigueur in many countries during the height of the pandemic. 5
Phylogenetic information can also contribute to estimating upper RR, by allowing a dis-
tinction to be made between viruses imported into a population and those that have
spread within it. Such phylogenetic analysis was used to establish the origin of the
virus from Wuhan.
References
Ferrarini MG et al (2021) Genome-wide bioinformatics analyses predict key host and viral factors
in SARS-CoV-2 pathogenesis. Commun Biol 4:590
Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo RM (2020) Early dynamics
of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis
20:553–558
Swadi T et al (2021) Genomic evidence of in-flight transmission of SARS-CoV-2 despite prede-
parture testing. Emerg Infect Dis 27:687–693
Thomas P (2020) J-value assessment of how best to combat COVID-19. Nanotechnol Percept
16:16–40
Thomas P (2022) Modeling the epidemic of the COVID-19 omicron variant in England. Nanotechnol
Percept 18:89–115
4 Ferrarini et al. (2021).
5 Swadi et al. (2021).